Brief: Evotec Gets USD 5 mln milestone payment from Bristol Myers Squibb

Evotec SE

12/11/2025 06:48

Nov 12 (Reuters) - Evotec SE EVTG.DE:

EVOTEC SE - GETS MILESTONE PAYMENT FROM BRISTOL MYERS SQUIBB FOLLOWING APPROVAL OF IND APPLICATION IN STRATEGIC PARTNERSHIP IN PROTEIN DEGRADATION FIELD

EVOTEC SE - THE DRUG CANDIDATE WAS DEVELOPED WITHIN THE PARTNERSHIP AND A PHASE 1 CLINICAL TRIAL IS EXPECTED TO BEGIN IN 2026.

EVOTEC SE - FDA APPROVAL OF IND APPLICATION TRIGGERS MILESTONE PAYMENT OF US$ 5 MILLION TO EVOTEC

Further company coverage: EVTG.DE

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))